Literature DB >> 7918377

Factor VIIa residue Arg290 is required for efficient activation of the macromolecular substrate factor X.

W Ruf1.   

Abstract

The serine protease factor VIIa (VIIa) in complex with tissue factor is responsible for initiating proteolytic events in the coagulation pathways. Efficient proteolysis by the extrinsic activation complex appears to depend on structural determinants in the cofactor as well as the light and heavy chain domains of VIIa. This study characterizes the functional defect resulting from alanine replacement for R290 in the VIIa protease domain. VIIa R290-->A bound both full-length and soluble tissue factor with affinities indistinguishable from wild-type VIIa, consistent with overall unaltered folding of the mutant protein. The catalytic function of VIIa R290-->A was further demonstrated to be unperturbed when analyzed with three different peptidyl p-nitroanilide substrates, indicating that the function of the catalytic triad is not affected by the mutation. However, proteolytic activation of factor X was diminished due to a 4-5-fold decreased kcat in the presence and a > 10-fold decreased rate in the absence of a negatively charged phospholipid surface. The functional defect resulting from the R290-->A replacement was observed in the presence and absence of cofactor. Within the structural framework of serine protease domains, R290 is predicted to be localized in a surface-exposed loop suggested to contribute to substrate selectivity in other serine proteases, consistent with the proposed functional role of R290 in the proteolytic activation of the natural substrate factor X.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918377     DOI: 10.1021/bi00204a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.

Authors:  L Perera; T A Darden; L G Pedersen
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

2.  Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.

Authors:  S Dittmar; W Ruf; T S Edgington
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

3.  Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.

Authors:  C D Dickinson; C R Kelly; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Surface-loop residue Lys316 in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition.

Authors:  J A Kolkman; K Mertens
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

5.  Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.

Authors:  Anders B Sorensen; Inga Tuneew; L Anders Svensson; Egon Persson; Henrik Østergaard; Michael Toft Overgaard; Ole H Olsen; Prafull S Gandhi
Journal:  J Biol Chem       Date:  2019-12-04       Impact factor: 5.157

Review 6.  Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex.

Authors:  Chang Jun Lee; Vasu Chandrasekaran; Sangwook Wu; Robert E Duke; Lee G Pedersen
Journal:  Thromb Res       Date:  2010-02-13       Impact factor: 3.944

7.  Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.

Authors:  B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

Review 8.  Structural biology of factor VIIa/tissue factor initiated coagulation.

Authors:  Kanagasabai Vadivel; S Paul Bajaj
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

9.  Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.

Authors:  J R Sevinsky; L V Rao; W Ruf
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.